Encapsulation of Anti-Tuberculosis Drugs within Mesoporous Silica and Intracellular Antibacterial Activities
2014 (English)In: Nanomaterials, ISSN 2079-4991, Vol. 4, no 3, 813-826 p.Article in journal (Refereed) Published
Tuberculosis is a major problem in public health. While new effective treatments to combat the disease are currently under development, they tend suffer from poor solubility often resulting in low and/or inconsistent oral bioavailability. Mesoporous materials are here investigated in an in vitro intracellular assay, for the effective delivery of compound PA-824; a poorly soluble bactericidal agent being developed against Tuberculosis (TB). Mesoporous materials enhance the solubility of PA-824; however, this is not translated into a higher antibacterial activity in TB-infected macrophages after 5 days of incubation, where similar values are obtained. The lack of improved activity may be due to insufficient release of the drug from the mesopores in the context of the cellular environment. However, these results show promising data for the use of mesoporous particles in the context of oral delivery with expected improvements in bioavailability.
Place, publisher, year, edition, pages
2014. Vol. 4, no 3, 813-826 p.
tuberculosis, mesoporous materials, solubility, intracellular, formulation, nanomedicine
Research subject Inorganic Chemistry
IdentifiersURN: urn:nbn:se:su:diva-108543DOI: 10.3390/nano4030813ISI: 000342202400016OAI: oai:DiVA.org:su-108543DiVA: diva2:764648